Equities Research Analysts’ Updated EPS Estimates for August, 10th (NCNA, NEOS, NEWT, NEXT, NIO, NMR, NMRK, NOMD, NOVT, NPTN)
Equities Research Analysts’ updated eps estimates for Saturday, August 10th:
NuCana (NASDAQ:NCNA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $11.00 price target on the stock. According to Zacks, “NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company’s pipeline of products includes Acelarin, NUC-3373 and NUC-7738 which are in clinical stage. NuCana PLC is based in EDINBURGH, United Kingdom. “
Neos Therapeutics (NASDAQ:NEOS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Neos Therapeutics, Inc. is engaged in developing, manufacturing and commercializing products for the treatment of attention deficit hyperactivity disorder using drug delivery technologies. Its product candidates include NT-0102 methylphenidate XR orally disintegrating tablet for the treatment of ADHD; NT-0202 amphetamine XR orally disintegrating tablet for the treatment of ADHD; NT-0201 amphetamine XR liquid suspension for the treatment of ADHD and Generic Tussionex, which are in different clinical development stage. Neos Therapeutics, Inc. is headquartered in Grand Prairie, Texas. “
NEWTEK Business Services (NASDAQ:NEWT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $23.00 price target on the stock. According to Zacks, “Newtek Capital, Inc. resulted from the combination of the businesses previously owned by BJB Holdings, Inc. and REXX Environmental Corporation and is operating as a holding company for a network of partner companies in a collaborative and coordinated effort to develop successful businesses in a number of existing as well as emerging, technological business lines. “
Nextdecade (NASDAQ:NEXT) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “NextDecade Corporation is a development and management company of land-based and floating LNG projects primarily in the global integrated natural gas industry. It principally focuses on a land-based project on the U.S. Gulf Coast called Rio Grande LNG in Brownsville, Texas. NextDecade Corporation is based in The Woodlands, United States. “
NIO (NYSE:NIO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “NIO Inc. is a premium electric vehicle market. The company designs, jointly manufactures and sells smart and connected premium electric vehicles. It offers electric cars under EP9, EVE and ES8 brand names. The company operates primarily in San Jose, California; Munich, Germany and London, United Kingdom. NIO Inc. is based in Shanghai, China. “
Nomura (NYSE:NMR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “NOMURA HLDG-ADR is a leading financial services group in Japan and has worldwide operations, providing a wide range of value-added financial services and competitive products. These include brokerage, trading, underwriting, M&A financial advisory services, merchant banking, and development and management of investment trusts and investment advisory services to diversified clients such as individuals, corporations, financial institutions, governments and governmental agencies. “
Newmark Group (NASDAQ:NMRK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $10.00 target price on the stock. According to Zacks, “Newmark Group, Inc. operates as a commercial real estate advisory firm. The Company offers services and products which includes investment sales, debt and structured finance and loan sales, agency leasing, property management, valuation and advisory and loan servicing. Newmark Group, Inc. is based in New York, United States. “
Nomad Foods (NYSE:NOMD) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Nomad Foods Ltd. manufactures and distributes frozen foods primarily in the United Kingdom, Italy, Germany, Sweden, France and Norway. The Company’s portfolio of frozen food brands includes Birds Eye, Iglo and Findus. Nomad Foods Ltd. is headquartered in Feltham, the United Kingdom. “
Novanta (NASDAQ:NOVT) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Novanta Inc. designs, develops, manufactures and sells precision photonic and motion control components and subsystems to original equipment manufacturers in the medical equipment and advanced industrial technology markets. Novanta Inc., formerly known as GSI Group Inc., is based in Bedford, Massachusetts. “
NeoPhotonics (NYSE:NPTN) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $7.25 target price on the stock. According to Zacks, “NeoPhotonics Corporation is engaged in the design and manufacture of photonic integrated circuit, or PIC, based modules and subsystems for bandwidth-intensive, high-speed communications networks. Products offered by the Company includes high-speed products that enable data transmission at 10Gbps, 40Gbps and 100Gbps, agility products such as ROADMs that dynamically allocate bandwidth to adjust for volatile traffic patterns, and access products that provide high-bandwidth connections to more devices and people over fixed and wireless networks. “
Napco Security Technologies (NASDAQ:NSSC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “NAPCO SECURITY SYSTEMS is engaged in the development, manufacture, distribution and sale of security alarm products and door security devices for commercial and residential installations. “
NTT DATA CORP/ADR (OTCMKTS:NTDTY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “NTT DATA Corp. is engaged in the development and integration of information technology and data communication systems. Its operating segment consists of Public and Financial IT Services, Enterprise IT Services, Solutions and Technologies, Global Business and Others. Public and Financial IT Services segment provides IT services which support social infrastructure in the public administration, healthcare and financial sectors. Enterprise IT Services segment offers IT services in the fields of manufacturing, retail, logistics, communications, broadcasting and utilities. Solutions and Technologies segment renders platforms and solutions that support IT services. Global Business segment delivers IT services. Others segment supports the business activities of the head office. NTT DATA Corp. is headquartered in Tokyo, Japan. “
NOVOZYMES A/S/S (OTCMKTS:NVZMY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company’s enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark. “
Quanex Building Products (NYSE:NX) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Quanex Building Products Corporation is an industry-leading manufacturer of components sold to Original Equipment Manufacturers in building products industry. Quanex designs and produces energy-efficient fenestration products in addition to kitchen and bath cabinet components. These components can be categorized as window and door (fenestration) components and kitchen and bath cabinet components. Examples of fenestration components include (1) energy-efficient flexible insulating glass spacers, (2) extruded vinyl profiles, (3) window and door screens, and (4) precision-formed metal and wood products. In addition, Quanex provide certain other non-fenestration components and products, which include solar panel sealants, wood flooring, trim moldings, vinyl decking, fencing, water retention barriers, and conservatory roof components. Quanex use low-cost production processes and engineering expertise to provide customers with specialized products for their specific window, door, and cabinet applications. “
Oaktree Strategic Income (NASDAQ:OCSI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $9.25 price target on the stock. According to Zacks, “Oaktree Strategic Income Corporation is a specialty finance company dedicated to providing customized capital solutions to middle-market companies. The firm seeks to generate stable, current income by providing innovative first-lien financing solutions to companies across a wide variety of industries. The company is regulated as a business development company, or a BDC, under the Investment Company Act of 1940, as amended. Oaktree Strategic Income is managed by Oaktree Capital Management, L.P. “
Oaktree Specialty Lending (NASDAQ:OCSL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Oaktree Specialty Lending Corporation is a specialty finance company. It provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company generates current income and capital appreciation by providing companies with flexible and innovative financing solutions including first and second lien loans, unsecured and mezzanine loans and preferred equity. Oaktree Specialty Lending Corporation, formerly known as Fifth Street Finance Corp., is based in CA, United States. “
Omeros (NASDAQ:OMER) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros’ most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders. “
Owens & Minor (NYSE:OMI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor’s customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. “
Receive News & Ratings for NuCana PLC Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for NuCana PLC and related companies with MarketBeat.com’s FREE daily email newsletter.
Original Source